Deutsche Bank’s Avidity Biosciences RNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.84M | Buy |
241,003
+56,388
| +31% | +$1.6M | ﹤0.01% | 1111 |
|
|
2025
Q1 | $5.45M | Sell |
184,615
-8,971
| -5% | -$265K | ﹤0.01% | 1210 |
|
|
2024
Q4 | $5.63M | Buy |
193,586
+30,340
| +19% | +$882K | ﹤0.01% | 1273 |
|
|
2024
Q3 | $7.5M | Buy |
163,246
+16,676
| +11% | +$766K | ﹤0.01% | 1112 |
|
|
2024
Q2 | $5.99M | Buy |
146,570
+11,821
| +9% | +$483K | ﹤0.01% | 1166 |
|
|
2024
Q1 | $3.44M | Sell |
134,749
-628,100
| -82% | -$16M | ﹤0.01% | 1404 |
|
|
2023
Q4 | $6.9M | Buy |
762,849
+628,299
| +467% | +$5.69M | ﹤0.01% | 1124 |
|
|
2023
Q3 | $858K | Buy |
134,550
+4,748
| +4% | +$30.3K | ﹤0.01% | 1804 |
|
|
2023
Q2 | $1.44M | Sell |
129,802
-35,203
| -21% | -$390K | ﹤0.01% | 1784 |
|
|
2023
Q1 | $2.53M | Buy |
165,005
+13,077
| +9% | +$201K | ﹤0.01% | 1559 |
|
|
2022
Q4 | $3.37M | Buy |
151,928
+10,678
| +8% | +$237K | ﹤0.01% | 1385 |
|
|
2022
Q3 | $2.31M | Buy |
141,250
+16,292
| +13% | +$266K | ﹤0.01% | 1554 |
|
|
2022
Q2 | $1.82M | Buy |
124,958
+2,442
| +2% | +$35.5K | ﹤0.01% | 1819 |
|
|
2022
Q1 | $2.26M | Sell |
122,516
-2,422
| -2% | -$44.7K | ﹤0.01% | 1808 |
|
|
2021
Q4 | $2.97M | Sell |
124,938
-220,372
| -64% | -$5.24M | ﹤0.01% | 1745 |
|
|
2021
Q3 | $8.51M | Buy |
345,310
+3,686
| +1% | +$90.8K | ﹤0.01% | 1224 |
|
|
2021
Q2 | $8.44M | Sell |
341,624
-132
| -0% | -$3.26K | ﹤0.01% | 1254 |
|
|
2021
Q1 | $7.45M | Buy |
341,756
+229,472
| +204% | +$5M | ﹤0.01% | 1341 |
|
|
2020
Q4 | $2.87M | Buy |
112,284
+3,348
| +3% | +$85.4K | ﹤0.01% | 1669 |
|
|
2020
Q3 | $3.07M | Buy |
108,936
+8,936
| +9% | +$252K | ﹤0.01% | 1485 |
|
|
2020
Q2 | $2.83M | Buy |
+100,000
| New | +$2.83M | ﹤0.01% | 1591 |
|